|Articles|March 1, 1999

March 1999
Volume 5
Issue 3

Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: A Practical Approach

Author(s)Dell B. Mather, PharmD, Sean D. Sullivan, PhD, Darren Augenstein, PharmD, MBA

Download PDF: Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: A Practical Approach

Articles in this issue

almost 27 years ago

Article

Economic Impact of Delaying or Preventing AIDS in Persons with HIV

almost 27 years ago

Article

Dissecting Cost-Effectiveness Analysis for Preventive Interventions: A Guide for Decision Makers

almost 27 years ago

Article

Opportunities for Improving Managed Care for Individuals with Dementia: Part I - The Issues

almost 27 years ago

Article

Opportunities for Improving Managed Care for Individuals with Dementia: Part II - A Framework for Care

almost 27 years ago

Article

Erectile Dysfunction: The Primary Care Practitioner's View

almost 27 years ago

Article

Drug-Nutrient Interactions

almost 27 years ago

Article

Evidence-Based Decision Making: Using Submission Guidelines to Inform Formulary Approvals

almost 27 years ago

Article

Correspondence regarding, "Clinic Visits and Hospital Admissions for Care of Acid-related Upper Gastrointestinal Disorders in Women Using Alendronate for Osteoporosis"

almost 27 years ago

Article

Correspondence regarding, "Insurance Type and the Transportation to Emergency Departments of Patients With Acute Cardiac Ischemia"

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

A Health Economic Evaluation of Digital Digestive Care Management

ByMartha Shepherd, DO, MPH,Pen-Che Ho, MS,David Hines, BA,Jon Harris-Shapiro, BA,Dena Bravata, MD, MS,Christopher M. Whaley, PhD,K. Davina Frick, PhD,Emmanuel F. Drabo, PhD,Ron Z. Goetzel, PhD

January 21st 2026

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

ByShamsi Atefeh, PhD

January 15th 2026

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

ByMohamed M. Ali, MS,Scott Lunos, MS,Zachary Henderson, BSB,Michele Allen, MD, MS,Patricia Adam, MD, MSPH,Genevieve B. Melton, MD, PhD,Rubina Rizvi, MD, PhD

January 12th 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: A Practical Approach

Articles in this issue

Newsletter

Related Content

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

A Health Economic Evaluation of Digital Digestive Care Management

Empowering Children and Parents Through Technology: Opportunities, Challenges, and Future Directions

Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps

Novel CLL Therapies Prompt New Treatment Considerations

Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD

ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC

Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns